99 related articles for article (PubMed ID: 23774926)
1. [Expression and clinical significance of glycoprotein non-metastatic melanoma protein B in human renal cell carcinoma].
Qin CP; Xiao YB; Liu ZH; Xie J; Yuan YQ; Hao YC; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 45(3):448-51. PubMed ID: 23774926
[TBL] [Abstract][Full Text] [Related]
2. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
3. [Expression of glycoprotein non-metastatic melanoma protein B in prostate cancer and its significance].
Xiao YB; Qiao ZG; Zhang XW; Liu ZH; Xie J; Hao YC; Yu WD; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):496-9. PubMed ID: 21844952
[TBL] [Abstract][Full Text] [Related]
4. [Expression of glycoprotein non-metastatic melanoma protein B in clear-cell renal cell carcinoma and clinical implication thereof].
He C; Qin C; Xu T; Yuan Y; Liu Z; Sheng Z; Hu F; Dun Y; Wang X
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2455-8. PubMed ID: 26711208
[TBL] [Abstract][Full Text] [Related]
5. Expression of glycoprotein non-metastatic melanoma protein B in cutaneous malignant and benign lesions: a tissue microarray study.
Zhao Y; Qiao ZG; Shan SJ; Sun QM; Zhang JZ
Chin Med J (Engl); 2012 Sep; 125(18):3279-82. PubMed ID: 22964323
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy.
Qin C; Liu Z; Yuan Y; Zhang X; Li H; Zhang C; Xu T; Wang X
Mol Med Rep; 2014 Mar; 9(3):851-6. PubMed ID: 24425288
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury.
Nakano Y; Suzuki Y; Takagi T; Kitashoji A; Ono Y; Tsuruma K; Yoshimura S; Shimazawa M; Iwama T; Hara H
Neuroscience; 2014 Sep; 277():123-31. PubMed ID: 25010402
[TBL] [Abstract][Full Text] [Related]
8. [Expression of P27kip1 in renal cell carcinoma and its clinical significance].
Wu P; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1883-6, 1889. PubMed ID: 20813693
[TBL] [Abstract][Full Text] [Related]
9. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.
Taya M; Hammes SR
Steroids; 2018 May; 133():102-107. PubMed ID: 29097143
[TBL] [Abstract][Full Text] [Related]
11. GPNMB promotes proliferation of developing eosinophils.
Hwang SM; Kang JH; Kim BK; Uhm TG; Kim HJ; Lee HH; Binas B; Chung IY
J Biochem; 2017 Aug; 162(2):85-91. PubMed ID: 28104809
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance].
Wang G; Qin W; Zheng J; Wei M; Zhou X; Wang H; Wen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):82-4, 88. PubMed ID: 23294722
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein non-metastatic melanoma protein b (Gpnmb) is highly expressed in macrophages of acute injured kidney and promotes M2 macrophages polarization.
Zhou L; Zhuo H; Ouyang H; Liu Y; Yuan F; Sun L; Liu F; Liu H
Cell Immunol; 2017 Jun; 316():53-60. PubMed ID: 28433199
[TBL] [Abstract][Full Text] [Related]
16. Gpnmb/osteoactivin: an indicator and therapeutic target in tumor and nontumorous lesions.
Zhuo H; Zhou L
Pharmazie; 2016 Oct; 71(10):555-561. PubMed ID: 29441921
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.
Xu A; Ahsanul Kabir Khan M; Chen F; Zhong Z; Chen HC; Song Y
Med Oncol; 2016 Nov; 33(11):131. PubMed ID: 27757783
[TBL] [Abstract][Full Text] [Related]
18. GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma.
Zhai JP; Liu ZH; Wang HD; Huang GL; Man LB
Oncol Lett; 2022 Jan; 23(1):36. PubMed ID: 34966452
[TBL] [Abstract][Full Text] [Related]
19. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
20. Effects of GPNMB on proliferation and odontoblastic differentiation of human dental pulp cells.
Wang YL; Hu YJ; Zhang FH
Int J Clin Exp Pathol; 2015; 8(6):6498-504. PubMed ID: 26261527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
